Medicare's drug pricing list didn't impact company stocks, here's why
Investor sentiment was indifferent towards the historic announcement Tuesday by the Biden Administration, which revealed the first 10 drugs that would face Medicare price negotiations next year under the Inflation Reduction Act. Stocks for all the US-publicly traded companies on the list — Bristol…
#medicare #bristolmeyerssquibb #bmy #elililly #lly #merck #astrazeneca #nvs #amgen #amgn